cs.LGNov 10, 2026

BioXArena-Pro: a research-grade benchmark for autonomous biomedical machine learning agents

Authors: Loka Li, Duzhen Zhang, Xingbo Du, Leonard Song, Kun Zhang, Le Song

Organizations: Mohamed bin Zayed University of Artificial Intelligence, Abu Dhabi, United Arab Emirates. · The Westminster Schools, Atlanta, Georgia, United States. · Carnegie Mellon University, Pittsburgh, Pennsylvania, United States.

Abstract

Coding agents are increasingly proposed as autonomous builders of biomedical models, but existing benchmarks are small, near saturation or open to leaked information. We present BioXArena-Pro, 64 research-level modelling tasks from eight biomedical domains, each rebuilt from a published study; most hold out whole biological units such as species or cohorts. Across 22 agent configurations, the best scores 55.1 of 100, and the scaffold matters almost as much as the model. We re-ran a published method for every task: where the published recipe applies unchanged, the best agent and the methods tie; on rebuilt tasks the methods trail by 8.2 points, suggesting that agents gain by adapting to new data. Pretrained models (including biological foundation models) matter where the strongest agent uses them: forbidding them decreases its score on those tasks by 9 points. Every task was audited in several AI-assisted rounds and a final human review.

Figures & tables

Explore similar work

May 7, 2026

BioMedArena: An Open-source Toolkit for Building and Evaluating Biomedical Deep Research Agents

Reproducing and comparing deep research agents today is hard: the same backbone evaluated on the same benchmark can report different accuracies across papers because the harness and tool registry differ, and integrating a new model into a comparable evaluation surface costs weeks of model-specific engineering. These are symptoms of a broader reproducibility problem in deep research agent research. Here, we introduce BioMedArena, an open-source toolkit that addresses this reproducibility gap and provides an arena for comparing deep research agents under a shared evaluation environment. BioMedArena decouples six layers of biomedical agent evaluation -- benchmark loading, tool exposure, tool selection, harness mode, context management, and scoring -- and exposes 166 biomedical benchmarks and 75 biomedical tools across 9 functional families. Adding a new model, benchmark, or tool can be accomplished with a few-line provider adapter. Beyond evaluation infrastructure, BioMedArena ships a library of high-quality reference components: 6 agent harnesses (including our proposed Mutual-Evolve) and 6 context-management strategies, any of which can be equipped on any backbone. Equipping these components substantially improves all 12 backbones; on each of 8 representative biomedical benchmarks, the best equipped backbone surpasses prior state-of-the-art (SOTA), by 15.01 percentage points on average. The toolkit, configurations, and per-task traces are available at https://github.com/AI-in-Health/BioMedArena.
Oct 18, 2026

Auto-MD-bench: Evaluating Autoresearch Agents for Real-World Medical Tasks

Autonomous agents are increasingly capable of developing machine learning (ML) models end to end. In medical practice, however, strong performance on the target metric does not fully characterize how good the models are in real-world use cases. For example, medical ML models should also provide well-calibrated risk estimates and remain robust across patient populations. Yet autonomous model development is typically guided by task objectives that emphasize simple predictive discrimination (e.g. AUROC). This raises a key question: are these objectives sufficient to guide agents toward models that meet the broader requirements of real-world medical use? In this study, we introduce Auto-MD-bench, a benchmark of 15 real-world medical tasks from 10 clinical datasets, spanning survival analysis, classification and sequential prediction, with external validation across cohorts, hospitals and time periods. We evaluate four agents: AIDE, AI Scientist v2, Codex, and Autoresearch. The strongest agents achieve competitive primary scores, yet their predicted risks are less calibrated than those of the simple baseline models, which could lead to severe medical accidents. Moreover, models with nearly identical primary scores can exhibit markedly different calibration, while performance varies substantially across population shifts. These findings show that primary task performance alone is insufficient to assess autonomous clinical modeling and multiple different metrics widely used in healthcare practice need to be taken into consideration.
Oct 6, 2026

BioStudyBench: Evaluating Agents on Post-Cutoff Biomedical Studies

We evaluate whether AI agents can match the reported findings of published biomedical studies using public data. Existing evaluations do not consistently separate analysis from prior knowledge or retrieval of the published answer. We introduce BioStudyBench, a benchmark of 25 long-horizon analysis tasks drawn from studies first published between July and September 2026, after the developer-reported knowledge cutoffs of the models we evaluate, semi-automatically filtered down from 404,019 PubMed records. In each task, the agent receives a neutral research question but no data files, so it must find and download the relevant public data, search the literature through tools that return only records dated before its cutoff, and report findings through data analysis. To measure gains over prior knowledge, we run every task both with and without access to data and tools. Across eight models, access to data and tools raises the pass rate by 47 percentage points on average over the no-data baseline. Open-weight models across sizes trail closed-weight models, with the best open-weight model passing 81.3% of tasks against 94.7% for the best closed-weight model.